Collegium Pharmaceutical Inc
NASDAQ:COLL
Collegium Pharmaceutical Inc
Cash from Operating Activities
Collegium Pharmaceutical Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
Cash from Operating Activities
$274.7m
|
CAGR 3-Years
43%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Operating Activities
$23.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Operating Activities
$13.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
12%
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Operating Activities
$8.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Operating Activities
$13B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
See Also
What is Collegium Pharmaceutical Inc's Cash from Operating Activities?
Cash from Operating Activities
274.7m
USD
Based on the financial report for Dec 31, 2023, Collegium Pharmaceutical Inc's Cash from Operating Activities amounts to 274.7m USD.
What is Collegium Pharmaceutical Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
10%
Over the last year, the Cash from Operating Activities growth was 121%. The average annual Cash from Operating Activities growth rates for Collegium Pharmaceutical Inc have been 43% over the past three years , 10% over the past five years .